Peptide therapy TikTok trends: separating hype from human data

What did @stormilly13 actually say?

Honestly? Almost nothing. The transcript reads: "That me own good. Don't get. Don't get. Don't get. Don't get. Don't get. Don't get." That's the whole thing. There's no coherent claim here, no peptide named, no mechanism described, no protocol recommended. Whatever @stormilly13 intended to communicate did not survive the transcription process, or possibly never existed in a communicable form.

The video is tagged under peptide therapy, which covers a wide range of compounds including BPC-157, TB-500, CJC-1295, ipamorelin, GHK-Cu, MK-677, semax, and selank. These are not interchangeable substances. They work through different pathways, carry different risk profiles, and have wildly different levels of human clinical evidence behind them. A video that gestures vaguely at this category without specifying anything is not informing its audience. It's just noise with good hashtags.

The caption adds "grrh" and a string of generic virality tags. There is no educational content here to evaluate on its merits.

Does the science back this up?

There's no specific claim to run through the literature, which is itself the problem. Peptide therapy content on TikTok tends to fall into two failure modes: overclaiming dramatic benefits without citing evidence, or being so vague that nothing can be verified or refuted. This video lands firmly in the second category.

What we can say is that the broader peptide space has a genuinely mixed evidentiary base. BPC-157 has shown tissue repair effects in rodent models (Sikiric et al., 2018, Current Pharmaceutical Design), but robust human trials are lacking. TB-500 (thymosin beta-4) has some wound healing data in animal studies but minimal human clinical evidence. Growth hormone secretagogues like CJC-1295 and ipamorelin have more structured human pharmacokinetic data, though long-term safety profiles remain understudied. MK-677, an oral ghrelin mimetic, has been studied in older adults for muscle and bone outcomes (Nass et al., 2008, Annals of Internal Medicine) with modest results and notable side effects including water retention and insulin resistance.

None of this matters for evaluating this specific video, because this video said nothing specific.

What did they get wrong (or right)?

There's nothing to credit and nothing to correct because there are no actual claims on the table. That's not a neutral outcome. When a video is categorized under peptide therapy and reaches nearly 2,000 viewers, the implicit message is that the creator knows something worth watching. Delivering incoherent audio under that banner is a form of misleading by omission.

Peptide therapy is a category where misinformation carries real risk. People self-inject unregulated compounds purchased from research chemical suppliers based partly on social media content. When creators in this space produce content that conveys authority without substance, they contribute to an information environment where patients make consequential health decisions without accurate guidance.

To be fair: @stormilly13 did not make any specific false claims. They did not name a peptide and overclaim its effects. They did not recommend a dose or a stack. In the narrowest sense, they cannot be accused of spreading misinformation because they did not spread any information at all. That's a low bar, and clearing it is not an achievement worth celebrating.

What should you actually know?

If you found this video while researching peptide therapy, here's what actually matters. Peptides are not a monolith. Each compound has its own mechanism, evidence base, and risk profile. Treating them as a generic category of "good for healing and optimization" is how people end up injecting substances without understanding what those substances do.

Compounded peptides obtained through telehealth platforms are not equivalent to FDA-approved drugs, and the regulatory landscape for compounded peptides has shifted significantly. The FDA has flagged several peptides including BPC-157 as not meeting the criteria for compounding under the FD&C Act. This does not mean these compounds have no biological activity. It means their safety and efficacy have not been established to the standard required for approved therapeutics.

If you're considering peptide therapy, the conversation should happen with a licensed clinician who can review your bloodwork, health history, and goals. A TikTok video, especially one that says "Don't get" six times and nothing else, is not a substitute for that conversation.

• Ask any provider recommending peptides which specific compound they're recommending and why.
• Request the evidence base they're drawing on, including whether that evidence comes from human trials or animal models.
• Understand the sourcing of any compounded peptide before use.